Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 223

Similar articles for PubMed (Select 17511879)

1.

The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.

Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL.

BMC Cancer. 2007 May 19;7:85.

2.

Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.

Crugliano T, Quaresima B, Gaspari M, Faniello MC, Romeo F, Baudi F, Cuda G, Costanzo F, Venuta S.

Int J Biochem Cell Biol. 2007;39(1):220-6. Epub 2006 Aug 30.

PMID:
17005433
3.

Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene.

Rio PG, Maurizis JC, Peffault de Latour M, Bignon YJ, Bernard-Gallon DJ.

Int J Cancer. 1999 Mar 15;80(6):823-6.

PMID:
10074913
4.

Expression of human protein phosphatase-1 in Saccharomyces cerevisiae highlights the role of phosphatase isoforms in regulating eukaryotic functions.

Gibbons JA, Kozubowski L, Tatchell K, Shenolikar S.

J Biol Chem. 2007 Jul 27;282(30):21838-47. Epub 2007 Jun 1.

5.

Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.

Saunus JM, French JD, Edwards SL, Beveridge DJ, Hatchell EC, Wagner SA, Stein SR, Davidson A, Simpson KJ, Francis GD, Leedman PJ, Brown MA.

Cancer Res. 2008 Nov 15;68(22):9469-78. doi: 10.1158/0008-5472.CAN-08-1159.

6.

Identification and functional characterization of a PP1-binding site in BRCA1.

Hsu LC.

Biochem Biophys Res Commun. 2007 Aug 24;360(2):507-12. Epub 2007 Jun 26.

7.

RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer.

Emberley ED, Gietz RD, Campbell JD, HayGlass KT, Murphy LC, Watson PH.

BMC Cancer. 2002 Nov 6;2:28.

8.

BRCA1 transcriptionally regulates genes involved in breast tumorigenesis.

Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA, King MC.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7560-5.

9.

RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.

Martin RW, Orelli BJ, Yamazoe M, Minn AJ, Takeda S, Bishop DK.

Cancer Res. 2007 Oct 15;67(20):9658-65.

10.

Haplo-insufficiency of BRCA1 in sporadic breast cancer.

Staff S, Isola J, Tanner M.

Cancer Res. 2003 Aug 15;63(16):4978-83.

11.

BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles.

Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD, Richardson AL.

Breast Cancer Res Treat. 2005 May;91(2):179-86.

PMID:
15868446
12.

BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions.

Yarden RI, Papa MZ.

Mol Cancer Ther. 2006 Jun;5(6):1396-404. Review.

13.

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.

Litwiniuk MM, Roznowski K, Filas V, Godlewski DD, Stawicka M, Kaleta R, Breborowicz J.

BMC Cancer. 2008 Apr 13;8:100. doi: 10.1186/1471-2407-8-100.

14.

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

Pinilla SM, Honrado E, Hardisson D, Benítez J, Palacios J.

Breast Cancer Res Treat. 2006 Sep;99(1):85-90. Epub 2006 Mar 16.

PMID:
16541313
15.

Analysis of specific interactions of native protein phosphatase 1 isoforms with targeting subunits.

Colbran RJ, Carmody LC, Bauman PA, Wadzinski BE, Bass MA.

Methods Enzymol. 2003;366:156-75.

PMID:
14674248
16.

Proteomic characterization of protein phosphatase 1 complexes in ischemia-reperfusion and ischemic tolerance.

Cid C, Garcia-Bonilla L, Camafeita E, Burda J, Salinas M, Alcazar A.

Proteomics. 2007 Sep;7(17):3207-18.

PMID:
17683050
17.

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Dopazo J, Rivas C, Benítez J.

Breast Cancer Res Treat. 2005 Mar;90(1):5-14.

PMID:
15770521
18.

A new alternative splice variant of BRCA1 containing an additional in-frame exon.

Fortin J, Moisan AM, Dumont M, Leblanc G, Labrie Y, Durocher F, Bessette P, Bridge P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M, Provencher L, Voyer P, Simard J.

Biochim Biophys Acta. 2005 Oct 15;1731(1):57-65. Epub 2005 Sep 13.

PMID:
16185777
19.

Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.

Walker LC, Waddell N, Ten Haaf A; kConFab Investigators, Grimmond S, Spurdle AB.

Breast Cancer Res Treat. 2008 Nov;112(2):229-36. Epub 2007 Dec 20.

PMID:
18095154
20.

BCoR-L1 variation and breast cancer.

Lose F, Arnold J, Young DB, Brown CJ, Mann GJ, Pupo GM; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Khanna KK, Chenevix-Trench G, Spurdle AB.

Breast Cancer Res. 2007;9(4):R54. Erratum in: Breast Cancer Res. 2008;10(5):406.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk